{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:51:16Z","timestamp":1770961876538,"version":"3.50.1"},"reference-count":67,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"U.S. Food and Drug Administration Center of Excellence in Regulatory Science and Innovation","award":["1U01FD004320"],"award-info":[{"award-number":["1U01FD004320"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1002\/pds.3897","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T09:58:59Z","timestamp":1446026339000},"page":"26-34","source":"Crossref","is-referenced-by-count":21,"title":["Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens"],"prefix":"10.1002","volume":"25","author":[{"given":"Mehmet","family":"Burcu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Health Services Research; University of Maryland; Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Safer","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry and Pediatrics; Johns Hopkins Medical Institutions; Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Zito","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research; University of Maryland; Baltimore MD USA"},{"name":"Department of Psychiatry; University of Maryland; Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"issue":"2","key":"10.1002\/pds.3897-BIB0001|pds3897-cit-0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1002\/pds.3897-BIB0002|pds3897-cit-0002","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1002\/pds.3897-BIB0003|pds3897-cit-0003","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jaac.2014.04.015","article-title":"Pediatric psychopharmacology: Food and Drug Administration approval through the evidence lens","volume":"53","author":"Lorberg","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1002\/pds.3897-BIB0004|pds3897-cit-0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/cap.2013.0094","article-title":"Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications","volume":"24","author":"Burcu","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"10.1002\/pds.3897-BIB0005|pds3897-cit-0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1002\/pds.3897-BIB0006|pds3897-cit-0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/appi.ps.201200081","article-title":"Antipsychotic use by Medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade","volume":"64","author":"Zito","year":"2013","journal-title":"Psychiatr Serv"},{"issue":"5","key":"10.1002\/pds.3897-BIB0007|pds3897-cit-0007","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1475-6773.2012.01461.x","article-title":"The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children","volume":"47","author":"Matone","year":"2012","journal-title":"Health Serv Res"},{"issue":"12","key":"10.1002\/pds.3897-BIB0008|pds3897-cit-0008","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1002\/pds.3897-BIB0009|pds3897-cit-0009","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archpedi.153.12.1257","article-title":"Psychotherapeutic medication patterns for youths with attention-deficit\/hyperactivity disorder","volume":"153","author":"Zito","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1002\/pds.3897-BIB0010|pds3897-cit-0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003-2011","volume":"53","author":"Visser","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1002\/pds.3897-BIB0011|pds3897-cit-0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/2013.jamapediatrics.401","article-title":"Recent trends in childhood attention-deficit\/hyperactivity disorder","volume":"167","author":"Getahun","year":"2013","journal-title":"JAMA Pediatrics"},{"key":"10.1002\/pds.3897-BIB0012|pds3897-cit-0012","unstructured":"Murphey D Barry MC Vaughn BG Adolescent health highlight: mental health disorders http:\/\/www.childtrends.org\/?publications=mental-health-disorders"},{"key":"10.1002\/pds.3897-BIB0013|pds3897-cit-0013","unstructured":"Foster Children: HHS Guidance Could Help States Improve Oversight of Psychotropic Prescriptions GAO-12-201 Washington, D.C."},{"key":"10.1002\/pds.3897-BIB0014|pds3897-cit-0014","unstructured":"Children's Mental Health: Concerns Remain About Appropriate Services for Children in Medicaid and Foster Care GAO-13-15 Washington, D.C."},{"key":"10.1002\/pds.3897-BIB0015|pds3897-cit-0015","unstructured":"Foster Children: Additional Federal Guidance Could Help States Better Plan for Oversight of Psychotropic Medications Administered by Managed-Care Organizations GAO-14-362 Washington, D.C."},{"key":"10.1002\/pds.3897-BIB0016|pds3897-cit-0016","unstructured":"Foster Children: HHS Could Provide Additional Guidance to States Regarding Psychotropic Medications GAO-14-651T Washington, D.C."},{"key":"10.1002\/pds.3897-BIB0017|pds3897-cit-0017","unstructured":"U.S. Department of Health and Services Office of Inspector General Work Plan for Fiscal Year 2014 http:\/\/oig.hhs.gov\/reports-and-publications\/archives\/workplan\/2014\/Work-Plan-2014.pdf"},{"issue":"16","key":"10.1002\/pds.3897-BIB0018|pds3897-cit-0018","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/pds.3897-BIB0019|pds3897-cit-0019","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1002\/pds.3897-BIB0020|pds3897-cit-0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jaac.2014.04.023","article-title":"Risk of diabetes in children and adolescents exposed to antipsychotics: a nationwide 12-year case-control study","volume":"53","author":"Nielsen","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1002\/pds.3897-BIB0021|pds3897-cit-0021","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archpedi.162.10.929","article-title":"Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents","volume":"162","author":"McIntyre","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1002\/pds.3897-BIB0022|pds3897-cit-0022","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.932","article-title":"Adverse events in children and adolescents treated with antipsychotic medications","volume":"23","author":"Jerrell","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"10.1002\/pds.3897-BIB0023|pds3897-cit-0023","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1542\/peds.2011-0855","article-title":"Antipsychotic medication use among children and risk of diabetes mellitus","volume":"128","author":"Andrade","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/pds.3897-BIB0024|pds3897-cit-0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2008.007","article-title":"Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents","volume":"19","author":"Calarge","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1002\/pds.3897-BIB0025|pds3897-cit-0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A comparison of risperidone-induced weight gain across the age span","volume":"24","author":"Safer","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"18","key":"10.1002\/pds.3897-BIB0026|pds3897-cit-0026","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2013.281140","article-title":"APA targets unnecessary antipsychotic use","volume":"310","author":"Kuehn","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/pds.3897-BIB0027|pds3897-cit-0027","unstructured":"ABIM Foundation's Choosing Wisely American Psychiatric Association: five things physicians and patients should question http:\/\/www.choosingwisely.org\/doctor-patient-lists\/american-psychiatric-association\/"},{"key":"10.1002\/pds.3897-BIB0028|pds3897-cit-0028","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008559.pub2","article-title":"Atypical antipsychotics for disruptive behaviour disorders in children and youths","volume":"9","author":"Loy","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/pds.3897-BIB0029|pds3897-cit-0029","unstructured":"Centers for Disease Control and Prevention Ambulatory Health Care Data http:\/\/www.cdc.gov\/nchs\/ahcd\/about_ahcd.htm"},{"issue":"1","key":"10.1002\/pds.3897-BIB0030|pds3897-cit-0030","first-page":"13","article-title":"Trends in antipsychotic drug use by very young, privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1002\/pds.3897-BIB0031|pds3897-cit-0031","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10826-013-9713-6","article-title":"Psychotropic medication patterns in Medicaid-insured youth based on clinician-reported maltreatment status","volume":"23","author":"Burcu","year":"2014","journal-title":"J Child Fam Stud"},{"issue":"1","key":"10.1002\/pds.3897-BIB0032|pds3897-cit-0032","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamapsychiatry.2013.3074","article-title":"National trends in the mental health care of children, adolescents, and adults by office-based physicians","volume":"71","author":"Olfson","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1002\/pds.3897-BIB0033|pds3897-cit-0033","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/cap.2013.0133","article-title":"Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics","volume":"24","author":"Rodday","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"10.1002\/pds.3897-BIB0034|pds3897-cit-0034","doi-asserted-by":"crossref","first-page":"E1577","DOI":"10.1542\/peds.2010-1361","article-title":"Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management","volume":"129","author":"Rosato","year":"2012","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/pds.3897-BIB0035|pds3897-cit-0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamapediatrics.2014.1647","article-title":"Geographic variation in receipt of psychotherapy in children receiving attention-deficit\/hyperactivity disorder medications","volume":"168","author":"Gellad","year":"2014","journal-title":"JAMA Pediatrics"},{"issue":"2","key":"10.1002\/pds.3897-BIB0036|pds3897-cit-0036","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamapediatrics.2013.433","article-title":"Conflicting data on psychotropic use by children: two pieces to the same puzzle","volume":"167","author":"Rubin","year":"2013","journal-title":"JAMA Pediatrics"},{"issue":"12","key":"10.1002\/pds.3897-BIB0037|pds3897-cit-0037","first-page":"1225","article-title":"Quality of care for childhood attention-deficit\/hyperactivity disorder in a managed care Medicaid program","volume":"49","author":"Zima","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1002\/pds.3897-BIB0038|pds3897-cit-0038","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ps.201300455","article-title":"Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths","volume":"65","author":"Vanderwerker","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1002\/pds.3897-BIB0039|pds3897-cit-0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054152","article-title":"Stimulant and atypical antipsychotic medications for children placed in foster homes","volume":"8","author":"Linares","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1002\/pds.3897-BIB0040|pds3897-cit-0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11920-013-0382-3","article-title":"Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications","volume":"15","author":"Birnbaum","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"10.1002\/pds.3897-BIB0041|pds3897-cit-0041","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archpedi.158.8.753","article-title":"New users of antipsychotic medications among children enrolled in TennCare","volume":"158","author":"Cooper","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1002\/pds.3897-BIB0042|pds3897-cit-0042","first-page":"3","article-title":"A perilous disconnect: antipsychotic drug use in very young children","volume":"49","author":"Egger","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"16","key":"10.1002\/pds.3897-BIB0043|pds3897-cit-0043","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/jama.2009.1558","article-title":"Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents","volume":"302","author":"Varley","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/pds.3897-BIB0044|pds3897-cit-0044","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jama.2015.0763","article-title":"Medicaid prior authorization policies for pediatric use of antipsychotic medications","volume":"313","author":"Schmid","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/pds.3897-BIB0045|pds3897-cit-0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/cap.2014.0008","article-title":"The effects of prior authorization policies on Medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states","volume":"24","author":"Stein","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"11","key":"10.1002\/pds.3897-BIB0046|pds3897-cit-0046","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1176\/appi.ps.201300410","article-title":"Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008","volume":"65","author":"Fontanella","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"7","key":"10.1002\/pds.3897-BIB0047|pds3897-cit-0047","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1017\/S1461145712001320","article-title":"Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment","volume":"17","author":"Toteja","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"10.1002\/pds.3897-BIB0048|pds3897-cit-0048","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaac.2014.05.010","article-title":"Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children","volume":"53","author":"Kreider","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1002\/pds.3897-BIB0049|pds3897-cit-0049","unstructured":"American Academy of Child and Adolescent Psychiatry Practice parameter for the use of atypical antipsychotic medications in children and adolescents 2011 http:\/\/www.aacap.org\/App_Themes\/AACAP\/docs\/practice_parameters\/Atypical_Antipsychotic_Medications_Web.pdf"},{"issue":"2","key":"10.1002\/pds.3897-BIB0050|pds3897-cit-0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1461145704004146","article-title":"Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?","volume":"7","author":"Stahl","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1002\/pds.3897-BIB0051|pds3897-cit-0051","first-page":"18","article-title":"The dopamine dilemma: using stimulants and antipsychotics concurrently","volume":"7","author":"Yanofski","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"10.1002\/pds.3897-BIB0052|pds3897-cit-0052","first-page":"47","article-title":"The dopamine dilemma-part II: could stimulants cause tolerance, dependence, and paradoxical decompensation?","volume":"8","author":"Yanofski","year":"2011","journal-title":"Innov Clin Neurosci"},{"issue":"6","key":"10.1002\/pds.3897-BIB0053|pds3897-cit-0053","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pds.3768","article-title":"Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents","volume":"24","author":"Sohn","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1002\/pds.3897-BIB0054|pds3897-cit-0054","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1176\/appi.ps.201400222","article-title":"Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011","volume":"66","author":"Connolly","year":"2015","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1002\/pds.3897-BIB0055|pds3897-cit-0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pds.2062","article-title":"Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users","volume":"20","author":"Morrato","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1002\/pds.3897-BIB0056|pds3897-cit-0056","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jamapediatrics.2014.224","article-title":"Metabolic monitoring in commercially insured pediatric patients newly initiated to take a second-generation antipsychotic","volume":"168","author":"Delate","year":"2014","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"10.1002\/pds.3897-BIB0057|pds3897-cit-0057","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2010.48","article-title":"Metabolic screening in children receiving antipsychotic drug treatment","volume":"164","author":"Morrato","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"10.1002\/pds.3897-BIB0058|pds3897-cit-0058","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1542\/peds.2014-0828","article-title":"Adherence to guidelines for glucose assessment in starting second-generation antipsychotics","volume":"134","author":"Raebel","year":"2014","journal-title":"Pediatrics"},{"key":"10.1002\/pds.3897-BIB0059|pds3897-cit-0059","unstructured":"FDA Patient Safety News, Show #28 2004 http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/psn\/printer.cfm?id=229"},{"issue":"2","key":"10.1002\/pds.3897-BIB0060|pds3897-cit-0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1002\/pds.3897-BIB0061|pds3897-cit-0061","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"issue":"5 Suppl","key":"10.1002\/pds.3897-BIB0062|pds3897-cit-0062","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.acap.2014.05.009","article-title":"Quality concerns in antipsychotic prescribing for youth: a review of treatment guidelines","volume":"14","author":"Kealey","year":"2014","journal-title":"Acad Pediatr"},{"issue":"6","key":"10.1002\/pds.3897-BIB0063|pds3897-cit-0063","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/pds.3609","article-title":"Validation of a claims-based antipsychotic polypharmacy measure","volume":"23","author":"Leckman-Westin","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1002\/pds.3897-BIB0064|pds3897-cit-0064","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1542\/peds.2010-1510","article-title":"Contrasting parents' and pediatricians' perspectives on shared decision-making in ADHD","volume":"127","author":"Fiks","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/pds.3897-BIB0065|pds3897-cit-0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pec.2010.07.035","article-title":"Using freelisting to understand shared decision making in ADHD: parents' and pediatricians' perspectives","volume":"84","author":"Fiks","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"4","key":"10.1002\/pds.3897-BIB0066|pds3897-cit-0066","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.1542\/peds.2013-2516","article-title":"Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial","volume":"133","author":"Kolko","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/pds.3897-BIB0067|pds3897-cit-0067","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jpepsy\/jsl054","article-title":"Academic and educational outcomes of children with ADHD","volume":"32","author":"Loe","year":"2007","journal-title":"J Pediatr Psychol"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3897","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T22:58:06Z","timestamp":1625353086000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3897"}},"subtitle":["Antipsychotic Prescribing for Behavioral Disorders in U.S. Youth"],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3897","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10,28]]}}}